|

First-Line Dara-BorCyD Treatment Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Peking University First Hospital1

Indications

  • Light Chain (AL) Amyloidosis1
  • MRD1
  • Cancer1

Other1 trial

A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.